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Douglas G Altman‘If physicians are to base treatment decisions on the
evidence in the medical literature, all the relevant
results of trials must be available easily and
consistently. Yet it is common to have trouble
identifying the hypothesis, the research question, and
the design of a published trial. It is even more
common to lose count of the participants or to be
unable to tell who received what therapies and the
type of analysis used. As a result, it is often impossible
to know whether the conclusions are justified by the
data’ [1].
There is a big problem with journal articles. Readers
of published research reports, especially systematic re-
viewers, struggle to find key details of study methods
and often cannot extract the results they seek [1]. Many
research articles are clearly unfit for purpose [2].
What is the solution? One way is to develop text-
mining software to locate the relevant information, and
several groups are working on such initiatives [3-5]. But
text-mining is only a potential solution for extracting
information that is in fact there, albeit hard to locate; it
cannot assist at all for information that is simply absent
from the research report. There is a wealth of evidence
that key information is commonly missing from published
reports of trials [6,7]. So while text-mining software could
be useful for existing literature, going forwards with it is a
solution to the wrong problem. Instead, I believe we need
to consider a different format for publishing research
results.
Research reports published in journal articles serve
multiple readerships, each with different needs. Regardless
of length and style, it is essential that such articles include
all relevant details of the study methods and the key
findings. Two fundamental principles are that a researchCorrespondence: doug.altman@csm.ox.ac.uk
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unless otherwise stated.article should include enough information about the
methodology to allow others to replicate the study, and
the results should be given in enough detail to enable
them to be included in a subsequent systematic review
and meta-analysis [8]. In principle the format of a report
is irrelevant if those criteria are met. However, the
current standard story-telling format embeds factual in-
formation and numerical results within the narrative
text, making some details hard to extract and, crucially,
masking the absence of essential material. These prob-
lems affect all types of research but the seriousness is
arguably greatest in relation to reports of randomised
trials, which I will consider here.Deficiencies in journal articles
Reporting guidelines emerged in the 1990s in response to
the abundant evidence of missing or ambiguous informa-
tion in published research reports [9,10]. The Consolidated
Standards of Reporting Trials (CONSORT) Statement, first
published in 1996 and most recently updated in 2010 [11],
outlines the minimum information that should be included
in reports of the results of randomised trials. Approaching
20 years since its first appearance, its benefit on reporting
has been clearly seen, but with only modest improvement
over time [12].
Several hundred journals have stated support for, or
adoption of, CONSORT, but adherence remains inad-
equate. Dozens of recent reviews have shown that report-
ing of essential information continues to be generally
inadequate in trial reports across all areas of medicine
[6,7,13,14]. The present situation is clearly unacceptable.
Various ideas are being explored to improve the quality of
publications including some targeted at editorial pro-
cesses. Indeed improved reporting has been demonstrated
when editorial resources are focused specifically on adher-
ence to CONSORT [15-17]. One possibility that needs
serious consideration is to change the format of research
articles by introducing more structure.is an Open Access article distributed under the terms of the Creative Commons
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clinical practice. Improved completeness and clinical
value have been demonstrated, for example in pathology
[18], radiology [19], and telemedicine [20]. Structure in
research reports began with the adoption of the IMRAD
format (Introduction, Methods, Results and Discussion)
augmented by the adoption of structured abstracts [21].
Although in each case there were fears that the structure
would stifle creativity, both succeeded because of
their self-evident benefit on the quality of published
articles [22].
Structured reporting of research articles
Within medical research, trial registers provide a perfect
example of structured reporting. So, for example, regis-
tering a study on clinicaltrials.gov requires completion
of a structured template. Likewise, in the section for
subsequent reporting of the results, researchers have to
provide the study findings in a structured way. It has
been shown that some results posted on clinicaltrials.
gov, especially harms, are more complete than those in
corresponding journal articles reporting the same trials
[23,24].
Journal articles that report research findings are cur-
rently in a mainly narrative style, usually supported by ta-
bles and perhaps also figures. As Riveros and colleagues
observed, ‘using templates with mandatory reporting of
some elements may facilitate the work of researchers by
reminding them what they need to report and by standar-
dising their reporting’ [23]. It is timely to consider
whether journal articles would be more informative if they
had more structure.
There are two main forms of structure. First, more
structure can be applied to the main text by creating many
more sections. One of the antecedents of CONSORT was
SORT (Standards of Reporting Trials), a reporting guide-
line that referred to structured reporting in its title [25].
The authors defined structured reporting as providing suf-
ficiently detailed information about the design, conduct
and analysis of the trial for the reader to have confidence
that the report is an accurate reflection of what occurred
during the various stages of the trial. A single published
case study of using each item of the SORT checklist as a
heading for a short section was widely considered to be a
failure, as it made the article longer and less readable [22].
However, some of the criticisms were related more to the
content of SORT than the format. Three subsequent gen-
erations of the development of CONSORT have addressed
those concerns; it is not reasonable to continue to dismiss
the principle of structure based on a single case study
published 20 years ago using a different checklist. In
fact, much the same idea has been implemented else-
where. The journal PLoS Clinical Trials, published
from 2006–2007, created a template based on the thencurrent CONSORT checklist of 2001. Each item in the
CONSORT checklist was used a heading in the article.
Although this was in essence a repeat of the SORT ap-
proach, there were fewer headings and they were structured
within the IMRAD format.
Alternatively, authors can identify in the text where
each element of the CONSORT checklist is addressed
[26]. This approach has no impact on the format of the
article, but requires the authors to mark up the text.
While that format should help to avoid omissions, some
checklist items do not refer to a specific piece of infor-
mation in a single location, and so this is not in my view
a workable solution in general.
A different approach to structure is to adopt a more
tabular format akin to completing a tax form, as is
required for example on clinical trials registers. In fact,
several structural elements are already routinely used in
reports of randomised trials. Almost certainly the most
successful impact of CONSORT has been the flow dia-
gram, which is now included in the majority of published
trial reports. The diagram depicts the flow of participants
through the trial, from enrolment through allocation and
follow up to analysis. Readers, including peer reviewers,
can quickly see the numbers of randomised participants,
identify when and why some were lost to follow-up, and
the extent to which the numbers analysed reflect the
numbers randomised. Other structures within most re-
ports of trial results are a structured abstract and a table
showing the baseline characteristics of each intervention
group (usually as Table 1). But it is simple, and I believe
desirable, to include other elements within explicit dis-
plays (tables or boxes), such as eligibility criteria, details of
interventions, outcomes, and primary results. Currently,
such information is rarely included as a display in pub-
lished articles. The suggestion is intended to make key in-
formation easy to locate rather than to require a rigid
format. Thus the same displays can easily accommodate
the modified recommendations in several extensions to
CONSORT (http://www.consort-statement.org/extensions).
A similar idea has been proposed for articles reporting
prognostic studies of tumour markers [27].
Readability is often put forward as an argument
against structure. This would be a stronger argument if
current research reports were highly readable, but
many are not. One reason is that much factual infor-
mation is embedded within the text, which works espe-
cially poorly for trial results. Readability is certainly
desirable, but far more important are reliability and
relevance [28], and crucially important too is reprodu-
cibility, which of course requires complete reporting.
One reason for suggesting greater use of structural
elements is to pull apart factual information from nar-
rative, making it easier both to locate specific informa-
tion and also to understand the broad sweep of a study
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though they are.
Greater use of structure within research articles (not
just for randomised controlled trials) would improve
completeness by helping authors ensure they address
key issues. It would also greatly aid reviewers and editors
in appraising articles, and it would assist future system-
atic reviewers who currently struggle to find the key in-
formation they seek. Indeed, more structure would also
aid text-mining. In the future, trial results will perhaps
appear only in registries, presumably in a highly struc-
tured format, with journals carrying only narrative discus-
sions of their findings [29]. Such a radical change does not
seem imminent, however.
In the initial editorial published when Trials was
launched, the editors wrote that ‘we believe that there is
scope for new and better ways to report the findings of
trials. Trials will develop and refine innovative approaches
to improving communication about trials’ [30]. As yet
there has been very little activity on this theme. We en-
courage contributions, both suggestions for suitable for-
mats and also specific examples of real trial results
presented in alternative formats. This editorial is thus the
first contribution in a new Trials series on ‘New ways to
publish research findings’.
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